Related Experiment Video
Updated: Jan 3, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Effect of High-dose Vitamin A Supplementation in Children With Sickle Cell Disease: A Randomized, Double-blind,
Jefferson N Brownell1,2, Joan I Schall1, Carolyn R Mcanlis1
1Division of Gastroenterology, Hepatology, and Nutrition.
Insights
High-dose vitamin A supplementation did not improve vitamin A status in children with hemoglobin-SS disease (HbSS). However, it led to improvements in fetal hemoglobin and erythrocyte indices.
Area of Science:
- Pediatric Hematology
- Nutritional Science
- Clinical Research
Background:
- Suboptimal vitamin A status is linked to adverse outcomes in children with hemoglobin-SS disease (HbSS).
- Standard Recommended Daily Allowance (RDA) of retinol is ineffective for improving vitamin A status in this population.
Purpose of the Study:
- To compare vitamin A and nutritional status in children with HbSS versus healthy children.
- To explore the impact of high-dose vitamin A supplementation on serum vitamin A status and other health parameters in children with HbSS.
Main Methods:
- A single-center, randomized, blinded, dose-finding pilot study.
- 22 children with HbSS were randomized to receive 3000 or 6000 IU/d of oral retinol for 8 weeks.
- Mixed-effects linear regression was used to analyze associations between vitamin A dose, serum retinol, and outcomes.
Main Results:
- Children with HbSS exhibited suboptimal serum retinol, growth, and nutritional status at baseline.
- Vitamin A supplementation did not alter serum vitamin A levels.
- Significant improvements were observed in fetal hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration.
Conclusions:
- High-dose vitamin A supplementation does not improve vitamin A status in children with HbSS.
- Supplementation showed positive effects on hematologic parameters, including fetal hemoglobin and erythrocyte indices.
- Mild improvements in growth and muscle function were noted, independent of hydroxyurea treatment.
Abstract:
Suboptimal vitamin A status (serum retinol <30 µg/dL) is associated with poor clinical outcomes in children with the hemoglobin-SS disease (HbSS), and supplementation with the recommended daily allowance of retinol is ineffective in improving vitamin A status. In a single-center randomized blinded dose-finding pilot study, we compared vitamin A and nutritional status in children with HbSS to healthy children and explored the impact of high-dose supplementation on the primary outcome serum vitamin A status. Exploratory outcomes included hematologic, nutritional, immunologic, and muscle function status in children with HbSS. A mixed-effects linear regression model evaluated associations between vitamin A dose, serum retinol, and exploratory outcomes. Twenty healthy children participated, and 22 subjects with HbSS were randomized to oral 3000 or 6000 IU/d retinol for 8 weeks; 21 subjects completed all evaluations. Serum retinol, growth, and nutritional status were all suboptimal in HbSS subjects at baseline, and supplementation did not change vitamin A status. Fetal hemoglobin (Δ=2.5, 95% confidence interval [CI], 0.5-4.3), mean corpuscular volume (Δ=2.7, 95% CI, 0.7-4.7), mean corpuscular hemoglobin (Δ=1.4, 95% CI, 0.5-2.3), and mean corpuscular hemoglobin concentration (Δ=0.5, 95% CI, 0.1-0.9) all improved with supplementation. Mild improvements in erythrocyte indices, growth status, and muscle function occurred independent of hydroxyurea use.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Single Versus Multiple Dose Studies